Antibody Response to mRNA-1273 SARS-CoV-2 Vaccine in Hemodialysis Patients with and without Prior COVID-19.

Patients on maintenance hemodialysis (HD) are highly susceptible to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection ([1][1]). Work by us and others shows that patients on maintenance HD mount an antibody (Ab) response following SARS-CoV-2 infection, but the Ab titers decline